Compounded semaglutide,
delivered everywhere.
Cora Health provides compounded semaglutide via licensed telehealth providers to residents of all 50 US states. $99/month all-inclusive on the annual plan — prepared by Hallandale Pharmacy or VialsRx, both US-licensed 503A compounding pharmacies (PCAB-accredited). Compounded medications are not FDA-approved and are not therapeutically equivalent to Ozempic® or Wegovy®.
Compounded semaglutide is a US-licensed 503A pharmacy preparation of the same active molecule as brand-name Ozempic® (for type 2 diabetes) and Wegovy® (for chronic weight management) — a GLP-1 receptor agonist. It is NOT FDA-approved and is NOT therapeutically equivalent to the branded products — the FDA does not review compounded medications for safety, effectiveness, or manufacturing quality before they reach patients. Cora Health connects patients in all 50 US states with licensed providers at Wasef Health, PC who evaluate each patient and, when clinically appropriate, write a patient-specific prescription. Cora's Essential Plan delivers compounded semaglutide from $99/month all-inclusive on the annual commitment — covering provider consultation, medication, free expedited shipping, and ongoing monitoring. The STEP 1 trial (Wilding et al., New England Journal of Medicine, 2021) reported approximately 14.9% mean weight loss over 68 weeks with FDA-approved branded semaglutide (Wegovy®) at the 2.4mg dose. Compounded versions have not been independently evaluated at trial scale. Individual results vary.
Cora Health Essential Plan — compounded semaglutide pricing
Four commitment tiers, all-inclusive of the licensed-provider consultation, the medication, US-licensed 503A pharmacy fulfillment, free expedited shipping, and ongoing provider monitoring. No separate membership fee, no per-dose surcharge.
| Commitment | Monthly | Billed | Notes |
|---|---|---|---|
| Annual (12 months) | $99/mo | $1,188 every 12 months | Lowest per-month cost |
| Semi-Annual (6 months) | $120/mo | $720 every 6 months | Mid-commitment savings |
| Quarterly (3 months) | $145/mo | $435 every 3 months | Shortest committed savings tier |
| Monthly | $175/mo | $175/month | No commitment; cancel anytime |
For comparison: brand-name Wegovy® lists at approximately $1,349/month retail without insurance. Novo Nordisk's NovoCare direct-pay program offers oral Wegovy pills at $149/month (limited-time offer through August 31, 2026 per Novo Nordisk's published terms) and pen formulations at $199-$399/month depending on dose. See full breakdown at /semaglutide-cost/.
Major US metro areas
Cora Health serves the 20 largest US metropolitan areas with dedicated landing pages covering local healthcare context, state pharmacy regulations, neighborhood-level coverage, and metro-specific FAQs.
- New York City New York
- Los Angeles California
- Chicago Illinois
- Dallas-Fort Worth Texas
- Houston Texas
- Washington DC Virginia
- Philadelphia Pennsylvania
- Miami Florida
- Atlanta Georgia
- Boston Massachusetts
- San Francisco Bay Area California
- Phoenix Arizona
- Inland Empire California
- Detroit Michigan
- Seattle Washington
- Minneapolis-St. Paul Minnesota
- Tampa Bay Florida
- San Diego California
- Denver Colorado
- Baltimore Maryland
Find compounded semaglutide in your state
Each state page includes specific availability information, local pricing, FAQs about telehealth GLP-1 in that state, and details on Cora Health's coverage in your area. Click your state below to view the dedicated landing page.
Northeast
South
Midwest
West
Frequently asked questions about compounded semaglutide
What is compounded semaglutide and how does it differ from brand-name Ozempic or Wegovy?
Compounded semaglutide is a US-licensed 503A pharmacy preparation containing the same active molecule (semaglutide, a GLP-1 receptor agonist) as Novo Nordisk's FDA-approved brand-name products Ozempic® (for type 2 diabetes), Wegovy® (for chronic weight management), and Rybelsus® (oral semaglutide for type 2 diabetes). Compounded versions are NOT FDA-approved, NOT therapeutically equivalent to the branded products, and have not been independently evaluated in large clinical trials. The FDA does not review compounded medications for safety, effectiveness, or manufacturing quality. The pricing difference reflects different production economics — compounded versions are produced by smaller-scale 503A pharmacies, not by FDA-inspected commercial manufacturing.
How much does compounded semaglutide cost at Cora Health?
Cora Health's Essential Plan offers compounded semaglutide at four commitment tiers, all-inclusive of the provider visit, medication, and shipping: $99/month on the annual commitment ($1,188 billed yearly), $120/month on the semi-annual commitment, $145/month on the quarterly commitment, and $175/month on the monthly plan with no commitment. There is no separate membership fee, no per-dose surcharge, and no in-person visit required for most patients. For comparison, brand-name Wegovy® has a list price of approximately $1,349/month at major US pharmacies without insurance; Novo Nordisk's NovoCare direct-pay program offers oral Wegovy pills at $149/month (limited-time offer through August 31, 2026) and pen formulations at $199-$399/month depending on dose. See the full breakdown at /semaglutide-cost/.
Is compounded semaglutide safe?
Safety depends meaningfully on the specific compounding pharmacy preparing the medication. Cora Health's compounded semaglutide is fulfilled by Hallandale Pharmacy (PCAB-accredited, operating since 2003) or VialsRx (US-licensed 503A facility) — both named publicly so patients can independently verify credentials. Both pharmacies operate under USP 795 (non-sterile) and USP 797 (sterile compounding) standards. That said, compounded medications are not reviewed by the FDA for safety, effectiveness, or manufacturing quality before they reach patients, and side effects associated with the semaglutide molecule (nausea, vomiting, diarrhea, constipation, abdominal pain) apply to compounded versions. Cora Health is LegitScript-certified — independently verifiable at legitscript.com/websites/?checker_keywords=trycora.io. Patients should discuss risks and benefits with their prescribing provider.
How is compounded semaglutide prescribed online at Cora Health?
Cora Health does NOT prescribe medication. Cora Health connects patients with licensed providers at Wasef Health, PC (Michael Wasef, MD, named medical director). A patient completes an online assessment, the provider reviews the patient's health history and weight-related conditions, and — when clinically appropriate — writes a patient-specific prescription. The prescription is filled by Cora's partner US-licensed 503A pharmacy (VialsRx or Hallandale) and shipped directly to the patient via free expedited shipping. Ongoing patient-provider communication continues through the secure Cora Health patient portal for dose adjustments, side-effect management, and clinical questions. The provider may decline to prescribe if compounded semaglutide is not clinically appropriate for that patient.
What weight loss results can I expect from compounded semaglutide?
No large-scale published clinical trials have specifically evaluated compounded semaglutide. The headline efficacy numbers cited in semaglutide marketing come from trials of FDA-approved branded products. The pivotal STEP 1 trial (Wilding et al., New England Journal of Medicine, 2021) reported approximately 14.9% mean weight loss over 68 weeks at the maximum FDA-approved 2.4mg weekly dose of brand-name Wegovy®. SURMOUNT-5 (NEJM 2025) compared FDA-approved tirzepatide vs FDA-approved semaglutide head-to-head over 72 weeks and reported approximately 20.2% vs 13.7% mean weight loss. Compounded semaglutide may produce broadly similar effects when correctly dosed by a reputable pharmacy, but this is pharmacological reasoning, not trial-validated outcomes. Individual results vary substantially based on dose, adherence, lifestyle factors, and individual response. Compounded semaglutide is not FDA-approved.
About Cora Health's compounded semaglutide program
Cora Health connects patients with board-certified providers (Wasef Health, PC) for personalized GLP-1 weight loss treatment. The Essential Plan provides compounded semaglutide at $99/month on the annual commitment — covering the licensed-provider consultation, the medication, free expedited shipping anywhere in the US, and ongoing provider support. There is no separate membership fee, no per-dose price increase, and no in-person visit required for most patients.
Compounded semaglutide contains the same molecule (semaglutide, a GLP-1 receptor agonist) as brand-name Ozempic and Wegovy, but it is prepared by state-licensed compounding pharmacies rather than the original brand manufacturer. Compounded medications are not FDA-approved and have not been independently trialed. Clinical trial data for FDA-approved semaglutide (such as the 14.9% mean weight loss reported in the STEP 1 trial) reflects studies of the branded product, not compounded versions. Individual results vary.
For a full breakdown of compounded vs brand-name GLP-1 medications, see our complete comparison guide. To learn more about how telehealth GLP-1 prescribing works, see the complete guide to compounded semaglutide.